Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura
Articolo
Data di Pubblicazione:
2010
Citazione:
Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura / H.B. Feys, N. Vandeputte, R. Palla, F. Peyvandi, K. Peerlinck, H. Deckmyn, H.R. Lijnen, K. Vanhoorelbeke. - In: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. - ISSN 1538-7933. - 8:9(2010 Sep), pp. 2053-2062. [10.1111/j.1538-7836.2010.03942.x]
Abstract:
BACKGROUND: ADAMTS13 deficiency causes accumulation of unusually large von Willebrand factor molecules, which cross-link platelets in the circulation or on the endothelial surface. This process of intravascular agglutination leads to the microangiopathy thrombotic thrombocytopenic purpura (TTP). Most TTP patients have acquired anti-ADAMTS13 autoantibodies that inhibit enzyme function and/or clear it from the circulation. However, the reason for ADAMTS13 deficiency is not always easily identified in a subset of patients.
OBJECTIVES: To determine the origin of ADAMTS13 deficiency in a case of acquired TTP.
METHODS: Western blotting of ADAMTS13 in plasmas from acute and remission phases was used.
RESULTS: The ADAMTS13 deficiency was not caused by mutations or (detectable) autoantibodies; however, an abnormal ADAMTS13 truncated fragment (100 kDa) was found in acute-phase but not remission-phase plasma. This fragment resulted from enzymatic proteolysis, as recombinant ADAMTS13 was also cleaved when in the presence of acute-phase but not remission-phase plasma. Inhibitor screening showed that ADAMTS13 was cleaved by a serine protease that could be dose-dependently inhibited by addition of exogenous α₂ -antiplasmin. Examination of the endogenous α₂-antiplasmin antigen and activity confirmed deficiency of α₂ -antiplasmin function in acute-phase but not remission-phase plasma. To investigate the possibility of ADAMTS13 cleavage by plasmin in plasma, urokinase-type plasminogen activator was added to an (unrelated) congenital α₂ -antiplasmin-deficient plasma sample to activate plasminogen. This experiment confirmed cleavage of endogenous ADAMTS13 similar to that observed in our TTP patient
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
ADAMTS13; Plasmin; TTP
Elenco autori:
H.B. Feys, N. Vandeputte, R. Palla, F. Peyvandi, K. Peerlinck, H. Deckmyn, H.R. Lijnen, K. Vanhoorelbeke
Link alla scheda completa: